Muromachi Chemicals (4885) · TargetDropped
Establishment of New Manufacturing Facilities for Generic Drug Active Pharmaceutical Ingredients
First written in FY2021. 1 of 2 entries say "Dropped", first in FY2022. Latest entry: FY2022.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Establishment of New Manufacturing Facilities for Generic Drug Active Pharmaceutical IngredientsA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2022DroppedAnnual report
「Plans for construction of new facilities, disposals and other matters None.」
The plan for constructing new generic drug active pharmaceutical ingredient manufacturing facilities described in the previous period cannot be confirmed in this filing's plans for constructing or disposing of facilities. No explicit reason for its withdrawal is provided. - FY2021First statedAnnual report
「Head office pharmaceutical plant (Omuta, Fukuoka Prefecture) Pharmaceuticals business Active pharmaceutical ingredient manufacturing facilities 600,000 － Internal funds and borrowings Fiscal year ending May 2023 Fiscal year ending May 2024 500–700 tonnes per year」
For new projects involving generic drug active pharmaceutical ingredients, the company planned to invest ¥600 million, commence work in the fiscal year ending May 2023 and complete it in the fiscal year ending May 2024, with expected capacity of 500–700 tonnes per year after completion.